Drug Interaction Report

Sertraline and Tirofiban: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Tirofiban

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 532 documented Sertraline interactions, 477 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Combining sertraline with tirofiban can add up to a higher bleeding risk, so your care team will watch you closely and you should report any unusual bleeding promptly. Keep taking both as prescribed unless told otherwise.

Let's talk about taking sertraline (an antidepressant) together with tirofiban (a strong blood thinner given in the hospital, usually through an IV during heart-related care). Both can make bleeding more likely. Sertraline affects how your platelets use a chemical called serotonin, which normally helps blood clot, and tirofiban directly blocks platelets from sticking together. Put them together and the effect can add up.

You might notice easy bruising, nosebleeds, or bleeding that takes longer to stop. The good news is that tirofiban is given in a monitored setting, so your care team can watch you closely. Let your team know you take sertraline, and tell them right away if you see unusual bleeding.

Effect: Additive bleeding risk. Sertraline depletes platelet serotonin (impairing serotonin-mediated platelet aggregation), which compounds the direct platelet inhibition from tirofiban, a GP IIb/IIIa antagonist. This is a pharmacodynamic interaction; neither agent is a prodrug and no CYP-based mechanism is involved.

  • Direction: Increased bleeding tendency (additive on hemostasis).
  • Onset: Unspecified; tirofiban acts rapidly IV.
  • Evidence: Theoretical, supported by case-control/cohort SSRI + antiplatelet data.
  • Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, and overt/major hemorrhage; follow bleeding parameters and puncture sites during infusion. Dose is individualized and titrated by the care team.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of bleeding

Interaction Deep Dive

Combining an SSRI with an antiplatelet drug warrants caution, since the pairing may raise the likelihood of bleeding events32. Using sertraline together with an antiplatelet agent can heighten bleeding risk, an effect that may stem from sertraline's influence on serotonin release by platelets. Case-control and cohort investigations have found that concurrent use of selective serotonin and norepinephrine reuptake inhibitors (for example, sertraline) alongside antiplatelet agents carries an elevated bleeding risk. Reported bleeding events have encompassed epistaxis, ecchymosis, hematoma, petechiae, and life-threatening hemorrhages. During concurrent administration of sertraline and an antiplatelet agent, watch the patient for indications of heightened bleeding and advise patients regarding the increased bleeding risk 1.

Why it happens (mechanism)

Release of serotonin by platelets; additive effects on hemostasis

How to manage this interaction

Both medicines can raise bleeding risk, so the main step is closer monitoring, which is easy since tirofiban is given in a supervised hospital setting.

  • Keep taking both exactly as prescribed unless your care team tells you otherwise.
  • Make sure your team knows you take sertraline so they can watch you more closely.
  • Report any unusual bleeding right away: nosebleeds, bruising, tiny red skin spots, blood in urine or stool, or bleeding that won't stop.
  • Your team may adjust and individualize your treatment and monitor you more often to keep this safe.

Do not stop either medicine on your own; talk with your pharmacist or doctor first.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

3 reports — tap to read

a) A retrospective study involving patients older than 50 years diagnosed with acute myocardial infarction (N=27,058) found that using an SSRI together with any antiplatelet therapy significantly raised the bleeding risk by 1.42-fold relative to aspirin alone. Combined treatment with aspirin, clopidogrel, and an SSRI significantly elevated the risk by 2.35-fold compared with aspirin alone and by 1.57-fold compared with clopidogrel plus aspirin combination therapy 2.

b) A systematic review and meta-analysis encompassing 22 observational studies found that SSRI use was linked to a significant 1.55-fold rise in the risk of upper gastrointestinal bleeding (UGIB). The simultaneous use of SSRIs and antiplatelet agents was linked to a 2.48-fold increase in UGIB risk (3 studies) 3.

c) Case reports as well as epidemiological studies (case-control and cohort designs) have shown a link between the use of agents that impede serotonin reuptake and the occurrence of gastrointestinal bleeding. Drawing on published observational study data, exposure to SSRIs, especially during the month prior to delivery, has been associated with a less than 2-fold rise in the risk of postpartum hemorrhage. Bleeding events tied to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.

Common questions

Can I take Sertraline and Tirofiban together?

Combining sertraline with tirofiban can add up to a higher bleeding risk, so your care team will watch you closely and you should report any unusual bleeding promptly. Keep taking both as prescribed unless told otherwise. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sertraline and Tirofiban interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Sertraline and Tirofiban interaction managed?

Both medicines can raise bleeding risk, so the main step is closer monitoring, which is easy since tirofiban is given in a supervised hospital setting. Keep taking both exactly as prescribed unless your care team tells you otherwise. Make sure your team knows you take sertraline so they can watch you more closely. Report any unusual bleeding right away: nosebleeds, bruising, tiny red skin spots, b… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Sertraline or Tirofiban need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
  2. Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
  3. Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.